➢ SAA levels are significantly increased in COVID-19 patients and may be used as a diagnostic marker➢ The mean SAA concentration in critically-ill patients is significantly higher than in mild-ill patients, therefore may be used as a marker of disease severity in COVID-19. This evidence concerns the gene SAA1 and COVID-19.